{"disease":{"id":"blindness-acquired","name":"blindness acquired"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03173105","title":"Effects of Transcranial Direct Current Stimulation With Proprioceptive Training in Blind People","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Salgado Institute of Integral Health","has_results":false},{"nct_id":"NCT01927536","title":"Evaluating Color Perception Under LED Red/Green and Green Dominant Light","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03968991","title":"VISIODOL: Validation of the VISIODOL® Scale","phase":"NA","overall_status":"TERMINATED","enrollment_count":37,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03166566","title":"Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Federal University of Minas Gerais","has_results":false},{"nct_id":"NCT06117332","title":"AI-Powered Artificial Vision for Visual Prostheses","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":7,"lead_sponsor_name":"University of California, Santa Barbara","has_results":false},{"nct_id":"NCT03344848","title":"Early Feasibility Study of the Orion Visual Cortical Prosthesis System","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Second Sight Medical Products","has_results":false},{"nct_id":"NCT04634383","title":"A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness","phase":"NA","overall_status":"UNKNOWN","enrollment_count":5,"lead_sponsor_name":"Illinois Institute of Technology","has_results":false},{"nct_id":"NCT04312763","title":"A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals","phase":"","overall_status":"SUSPENDED","enrollment_count":3,"lead_sponsor_name":"Second Sight Medical Products","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}